Doximity Inc. (DOCS)
| Bid | 55.8 |
| Market Cap | 10.52B |
| Revenue (ttm) | 570.4M |
| Net Income (ttm) | 223.19M |
| EPS (ttm) | 1.11 |
| PE Ratio (ttm) | 50.47 |
| Forward PE | 40.11 |
| Analyst | Hold |
| Ask | 56.6 |
| Volume | 897,661 |
| Avg. Volume (20D) | 2,631,576 |
| Open | 56.29 |
| Previous Close | 55.92 |
| Day's Range | 55.73 - 57.06 |
| 52-Week Range | 25.00 - 85.21 |
| Beta | 1.32 |
About DOCS
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for DOCS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
1 week ago · proactiveinvestors.co.uk
Dr Martens surges 23% as investors lace up for recovery storyShares in Dr Martens PLC (LSE:DOCS) jumped 23% on Thursday after the bootmaker delivered a better-than-expected full-year update and signalled a shift towards stabilisation and future growth, giving i...
1 week ago · proactiveinvestors.co.uk
Dr Martens marketing 'reset' saw annual revenue and profit retreat, eyes return to growth this yearDr Martens PLC (LSE:DOCS) reported a 10% drop in group revenue to £787.6 million for the year ended 30 March 2025, amidst a marketing 'reset'. Adjusted profit before tax fell to £34.1 million from £97...
2 weeks ago · proactiveinvestors.co.uk
Dr Martens interims a first test for new CEO after shares stumble to all-time lowDr Martens PLC (LSE:DOCS) shares stumbled to a new all-time low below 50p last month after the US tariff announcement, but have been tiptoeing higher in the run-up to interim results due next Thursday...
